160 related articles for article (PubMed ID: 34906633)
21. Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Wentzensen N; Black A; Jacobs K; Yang HP; Berg CD; Caporaso N; Peters U; Ragard L; Buys SS; Chanock S; Hartge P
PLoS One; 2011; 6(7):e21731. PubMed ID: 21750727
[TBL] [Abstract][Full Text] [Related]
22. Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.
O'Grady TJ; Kitahara CM; DiRienzo AG; Boscoe FP; Gates MA
PLoS One; 2014; 9(9):e106880. PubMed ID: 25192282
[TBL] [Abstract][Full Text] [Related]
23. Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Hada M; Edin ML; Hartge P; Lih FB; Wentzensen N; Zeldin DC; Trabert B
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):189-197. PubMed ID: 30262599
[TBL] [Abstract][Full Text] [Related]
24. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
25. Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Chang VC; Khan AA; Huang WY; Katki HA; Purdue MP; Landgren O; Hofmann JN
Blood Cancer J; 2022 Apr; 12(4):51. PubMed ID: 35365600
[No Abstract] [Full Text] [Related]
26. Association of benign gynaecological diseases and risk of endometrial and ovarian cancers.
Shen F; Liu Y; Lin L; Zhao M; Chen Q
J Cancer; 2020; 11(11):3186-3191. PubMed ID: 32231723
[No Abstract] [Full Text] [Related]
27. Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial.
Grubb RL; Pinsky P; Prorok PC; Andriole GL
Eur Urol; 2015 Oct; 68(4):545-6. PubMed ID: 25959167
[TBL] [Abstract][Full Text] [Related]
28. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
Schoen RE; Weissfeld JL; Kuller LH
Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
[TBL] [Abstract][Full Text] [Related]
29. Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Barry SA; Tammemagi MC; Penek S; Kassan EC; Dorfman CS; Riley TL; Commin J; Taylor KL
J Natl Cancer Inst; 2012 Nov; 104(21):1647-59. PubMed ID: 23104210
[TBL] [Abstract][Full Text] [Related]
30. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC;
J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
Lacey JV; Kreimer AR; Buys SS; Marcus PM; Chang SC; Leitzmann MF; Hoover RN; Prorok PC; Berg CD; Hartge P;
BMC Cancer; 2009 Mar; 9():84. PubMed ID: 19292893
[TBL] [Abstract][Full Text] [Related]
32. Report of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development-sponsored workshop: gynecology and women's health-benign conditions and cancer.
Samimi G; Sathyamoorthy N; Tingen CM; Mazloomdoost D; Conroy J; Heckman-Stoddard B; Halvorson LM
Am J Obstet Gynecol; 2020 Dec; 223(6):796-808. PubMed ID: 32835714
[TBL] [Abstract][Full Text] [Related]
33. The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.
Zhu CS; Huang WY; Pinsky PF; Berg CD; Sherman M; Yu KJ; Carrick DM; Black A; Hoover R; Lenz P; Williams C; Hawkins L; Chaloux M; Yurgalevitch S; Mathew S; Miller A; Olivo V; Khan A; Pretzel SM; Multerer D; Beckmann P; Broski KG; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1635-1642. PubMed ID: 27635065
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Thomas DS; Gentry-Maharaj A; Ryan A; Fourkala EO; Apostolidou S; Burnell M; Alderton W; Barnes J; Timms JF; Menon U
Cancer Epidemiol; 2019 Feb; 58():167-174. PubMed ID: 30616086
[TBL] [Abstract][Full Text] [Related]
35. Calcium: magnesium intake ratio and colorectal carcinogenesis, results from the prostate, lung, colorectal, and ovarian cancer screening trial.
Zhao J; Giri A; Zhu X; Shrubsole MJ; Jiang Y; Guo X; Ness R; Seidner DL; Giovannucci E; Edwards TL; Dai Q
Br J Cancer; 2019 Oct; 121(9):796-804. PubMed ID: 31543516
[TBL] [Abstract][Full Text] [Related]
36. Sexual and physical abuse and gynecologic disorders.
Schliep KC; Mumford SL; Johnstone EB; Peterson CM; Sharp HT; Stanford JB; Chen Z; Backonja U; Wallace ME; Buck Louis GM
Hum Reprod; 2016 Aug; 31(8):1904-12. PubMed ID: 27334336
[TBL] [Abstract][Full Text] [Related]
37. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
[TBL] [Abstract][Full Text] [Related]
38. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.
Kramer BS; Gohagan J; Prorok PC; Smart C
Cancer; 1993 Jan; 71(2 Suppl):589-93. PubMed ID: 8420681
[TBL] [Abstract][Full Text] [Related]
39. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
Sturgeon SR; Pilsner JR; Arcaro KF; Ikuma K; Wu H; Kim SM; Chopra-Tandon N; Karpf AR; Ziegler RG; Schairer C; Balasubramanian R; Reckhow DA
Breast Cancer Res; 2017 Aug; 19(1):94. PubMed ID: 28821281
[TBL] [Abstract][Full Text] [Related]
40. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Doherty JA; Weiss NS
Cancer Causes Control; 2008 Dec; 19(10):1357-64. PubMed ID: 18704718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
